Response to Comment on: Barker et al. (2008) Two Single Nucleotide Polymorphisms Identify the Highest-Risk Diabetes HLA Genotype: Diabetes 57:3152–3155, 2008
- From the Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver, Denver, Colorado
- Corresponding author: Jennifer M. Barker, jennifer.barker{at}uchsc.edu
We thank Wijmenga and Romanos (1) for their response to our two–single nucleotide polymorphism (SNP) test for HLA-DR3/4-DQ8 (2). We agree that the DR3-DQ2 haplotype is an important genetic risk factor for both type 1 diabetes and celiac disease. Their use of SNP rs2187668 as a proxy of SNP rs2040410 to identify DR3-DQ2 should supplement our work because it can be useful for HLA typing using the TaqMan technique. We hope this cost- and time-efficient method will continue to benefit screening in large high-risk cohorts.
Acknowledgments
No potential conflicts of interest relevant to this article were reported.
Footnotes
-
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
- DIABETES
